This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Other. Active years: 2020-2022.
Company Filing History:
2 out of 834,453 Years Active: 2020-2022
Title: Célia Fontana: Innovator in Vaccine Development
Introduction
Célia Fontana is a prominent inventor based in Lyon, France. She has made significant contributions to the field of vaccine development, particularly in creating innovative solutions to combat infectious diseases. With a total of 2 patents, her work is recognized for its potential impact on animal health.
Latest Patents
Célia's latest patents include a live attenuated heterologous vaccine designed to elicit an immune response in animals against specific infections. This invention provides compositions or vaccines that contain a recombinant or an attenuated agent, along with methods of vaccination and kits for use with these compositions. Another notable patent focuses on immunoprotective proteins and methods for eliciting heterologous protective immunity in animals against various serovars. The immunoprotective peptides disclosed in this patent are designed to elicit protective immunity against subsequent challenges or exposures to at least two serovars.
Career Highlights
Throughout her career, Célia has worked with various organizations, including Vetagro Sup, where she has furthered her research and development efforts in veterinary medicine. Her innovative approaches have positioned her as a key figure in the field of immunology.
Collaborations
Célia has collaborated with notable colleagues such as Mathieu Picardeau and Natalia Ines Bomchil. These partnerships have enhanced her research and contributed to the advancement of vaccine technologies.
Conclusion
Célia Fontana's contributions to vaccine development highlight her dedication to improving animal health through innovative research. Her patents reflect her commitment to advancing the field and addressing critical health challenges.